Excision Surgery for Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common form of skin cancer, with millions of cases diagnosed annually worldwide. Excision surgery remains the gold standard for treating BCC, offering high cure rates when performed with appropriate margins. Understanding the nuances of BCC excision, including margin selection and CPT coding, is essential for both clinicians and patients. This article provides a comprehensive overview of excision of basal cell carcinoma, focusing on surgical techniques, margin recommendations, and billing considerations.

The primary goal of BCC removal is to completely excise the tumor while preserving healthy tissue and achieving optimal cosmetic outcomes. The success of excision surgery depends on several factors, including tumor size, location, histological subtype, and patient characteristics. A thorough preoperative assessment is crucial to determine the appropriate surgical approach and margin width.

Understanding BCC Excision

BCC excision involves the surgical removal of the tumor along with a surrounding margin of normal-appearing skin. The excised tissue is then sent to pathology for margin assessment. The procedure can be performed under local anesthesia in an outpatient setting, making it convenient and cost-effective. The BCC excision technique varies depending on the tumor's characteristics and the surgeon's preference. Standard excision uses a scalpel to remove the tumor with a predetermined margin, while Mohs micrographic surgery offers real-time margin control for high-risk tumors.

For low-risk BCCs, traditional excision with postoperative margin assessment is highly effective. Studies report five-year cure rates exceeding 95% for primary BCCs treated with adequate margins. However, the excision of BCC requires careful planning to balance complete removal with tissue conservation. Factors influencing margin selection include tumor size (greater than 2 cm often requires wider margins), location (central face, ears, and periorificial areas are high-risk), and histological subtype (aggressive growth patterns like infiltrative or micronodular require wider margins).

Excision Margins for BCC: Why They Matter

The BCC excision margins are the single most important factor determining the likelihood of complete tumor removal. Insufficient margins increase the risk of local recurrence, which can lead to more extensive surgery and potential morbidity. Current guidelines from the National Comprehensive Cancer Network (NCCN) recommend the following margin widths for standard excision of BCC:

• Low-risk BCC (well-defined, <2 cm, non-aggressive histology, on trunk or extremities): 4-5 mm clinical margin
• High-risk BCC (ill-defined, >2 cm, aggressive histology, or on high-risk areas like face): 5-10 mm or Mohs surgery
• Recurrent BCC: 10 mm or Mohs surgery

It is important to note that these margins are measured clinically (from the visible or palpable edge of the tumor) and may not correspond exactly to histological margins. After excision, the specimen is inked and sectioned to assess peripheral and deep margins. A positive margin indicates tumor extends to the edge of the excision, necessitating further treatment. Techniques to minimize positive margins include careful preoperative mapping, use of dermoscopy, and image-guided excision.

In some cases, a narrower margin of 2-3 mm may be appropriate for small, well-defined BCCs on the trunk or extremities, especially when cosmetic concerns are minimal. However, the goal of BCC removal is complete extirpation; therefore, compromise on margin adequacy is rarely justified. When margins are close (<1 mm histologically), close observation or re-excision may be recommended depending on the tumor location and patient factors.

BCC Excision CPT Codes

Accurate coding for BCC excision is essential for proper reimbursement and documentation. The Current Procedural Terminology (CPT) codes for excision of skin lesions are based on the excised diameter (lesion plus margin) rather than the lesion size alone. For BCC excision, the following CPT codes apply:

• 11600-11606: Excision of malignant lesion (including margins), trunk, arms, legs (codes vary by excised diameter: 11600 for ≤0.5 cm, 11601 for 0.6-1.0 cm, 11602 for 1.1-2.0 cm, 11603 for 2.1-3.0 cm, 11604 for 3.1-4.0 cm, 11606 for >4.0 cm)
• 11620-11626: Excision of malignant lesion, scalp, neck, hands, feet, genitalia (same diameter increments)
• 11640-11646: Excision of malignant lesion, face, ears, eyelids, nose, lips (same diameter increments)

When reporting the BCC excision CPT code, it is crucial to measure the total excised diameter (including margins) and document it in the operative note. The excised diameter is determined by adding twice the margin width to the lesion's largest diameter. For example, a 1 cm BCC excised with 4 mm margins would have an excised diameter of 1.8 cm, corresponding to CPT code 11602 (for trunk) or 11642 (for face).

Additional considerations include the use of complex closure codes (13100-13153) if layered repair is performed, or adjacent tissue transfer codes (14000-14302) for flaps. If Mohs micrographic surgery is performed, CPT codes 17311-17315 are used instead of excision codes. It is important to follow payer-specific guidelines and document medical necessity for the chosen procedure.

Postoperative Care and Follow-Up

After excision of BCC, proper wound care is essential to minimize infection, promote healing, and optimize scarring. Patients should keep the wound clean and dry for 24-48 hours, then gently clean with soap and water. Sutures are typically removed in 5-14 days depending on the surgical site. Sun protection is crucial to prevent recurrence and new primary lesions. Patients should use a broad-spectrum sunscreen with SPF 30+ daily and wear protective clothing.

Follow-up schedules vary based on risk stratification. For low-risk BCCs with clear margins, total body skin examinations every 6-12 months are sufficient. High-risk patients, such as those with recurrent disease, aggressive histology, or immunosuppression, may require more frequent monitoring. Patient education on self-examination and early warning signs of recurrence is vital.

Conclusion

BCC excision remains a highly effective treatment modality, offering excellent cure rates when appropriate margins are utilized. Understanding the interplay between tumor characteristics, margin selection, and CPT coding is essential for healthcare providers. By adhering to guideline-based margins and accurate documentation, clinicians can optimize outcomes and ensure appropriate reimbursement. Patients benefit from a tailored approach that balances efficacy with cosmesis. For complex or high-risk tumors, referral to a specialist trained in Mohs surgery or advanced reconstruction is recommended.

The landscape of BCC removal continues to evolve with advancements in imaging, molecular profiling, and non-surgical modalities. However, surgical excision with margin assessment remains the cornerstone of definitive treatment. By staying informed on best practices and coding updates, practitioners can deliver high-quality care while navigating the administrative aspects of skin cancer management.